Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies

Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies

Sponsor(s)

Sanofi Aventis

Principal Investigator(s)John Kauh, MD
Dates11/11/200 - 10/01/2010